Financials data is unavailable for this security.
View more
Year on year BioPharma Credit PLC grew revenues 10.53% from 135.73m to 150.03m while net income improved 12.66% from 108.45m to 122.18m.
| Gross margin | 82.96% |
|---|---|
| Net profit margin | 81.44% |
| Operating margin | 81.44% |
| Return on assets | 9.56% |
|---|---|
| Return on equity | 9.69% |
| Return on investment | 9.69% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at BioPharma Credit PLC fell by 129.43m. However, the company earned 111.91m from its operations for a Cash Flow Margin of 74.59%. In addition the company generated 39.07m cash from investing, though they paid out 280.42m more in financing than they received.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.9963 |
|---|---|
| Tangible book value per share | 0.9963 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.09 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share fell -22.22% while earnings per share excluding extraordinary items rose 20.68%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 8.71% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | 100.08% |
| EPS growth(5 years) | 2.34 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 20.51 |
More ▼
